Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study
Introduction: Venous thromboembolism (VTE) is a rare but potentially serious complication following anterior cruciate ligament reconstruction (ACLR). There is no guideline for the routine use of anticoagulants post-ACLR surgery. Methods: This retrospective case-control study reviewed 199 patients wh...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | SICOT-J |
| Subjects: | |
| Online Access: | https://www.sicot-j.org/articles/sicotj/full_html/2025/01/sicotj250049/sicotj250049.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849717521816485888 |
|---|---|
| author | Afana Hatem B. Ashokan Shine Nau Thomas |
| author_facet | Afana Hatem B. Ashokan Shine Nau Thomas |
| author_sort | Afana Hatem B. |
| collection | DOAJ |
| description | Introduction: Venous thromboembolism (VTE) is a rare but potentially serious complication following anterior cruciate ligament reconstruction (ACLR). There is no guideline for the routine use of anticoagulants post-ACLR surgery. Methods: This retrospective case-control study reviewed 199 patients who underwent ACLR between February 2020 and November 2024. Two groups were compared: Group A (n = 113) received no pharmacological prophylaxis, while Group B (n = 86) received low-molecular-weight heparin (LMWH) for 2 weeks postoperatively. The incidence of symptomatic VTE, postoperative bleeding, and related complications was evaluated. Results: No symptomatic VTE or bleeding complications were observed in either group. There was no statistically significant difference between the groups in terms of age, BMI, smoking, comorbidities, and postoperative weight bearing. There was a significant difference in surgical duration, graft type, and meniscal procedure. Discussion: Our findings support a risk-stratified approach rather than universal pharmacologic prophylaxis in ACLR patients. |
| format | Article |
| id | doaj-art-cc85ceea14074e10b486d3a3779847ec |
| institution | DOAJ |
| issn | 2426-8887 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | EDP Sciences |
| record_format | Article |
| series | SICOT-J |
| spelling | doaj-art-cc85ceea14074e10b486d3a3779847ec2025-08-20T03:12:38ZengEDP SciencesSICOT-J2426-88872025-01-01113810.1051/sicotj/2025032sicotj250049Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control studyAfana Hatem B.0https://orcid.org/0000-0003-3367-141XAshokan Shine1https://orcid.org/0009-0006-2298-2481Nau Thomas2https://orcid.org/0000-0003-4654-2991Orthopaedic Department, King’s College Hospital London DubaiOrthopaedic Department, King’s College Hospital London DubaiOrthopaedic Department, King’s College Hospital London DubaiIntroduction: Venous thromboembolism (VTE) is a rare but potentially serious complication following anterior cruciate ligament reconstruction (ACLR). There is no guideline for the routine use of anticoagulants post-ACLR surgery. Methods: This retrospective case-control study reviewed 199 patients who underwent ACLR between February 2020 and November 2024. Two groups were compared: Group A (n = 113) received no pharmacological prophylaxis, while Group B (n = 86) received low-molecular-weight heparin (LMWH) for 2 weeks postoperatively. The incidence of symptomatic VTE, postoperative bleeding, and related complications was evaluated. Results: No symptomatic VTE or bleeding complications were observed in either group. There was no statistically significant difference between the groups in terms of age, BMI, smoking, comorbidities, and postoperative weight bearing. There was a significant difference in surgical duration, graft type, and meniscal procedure. Discussion: Our findings support a risk-stratified approach rather than universal pharmacologic prophylaxis in ACLR patients.https://www.sicot-j.org/articles/sicotj/full_html/2025/01/sicotj250049/sicotj250049.htmlacl reconstructionthromboprophylaxisdeep vein thrombosisvenous thromboembolism |
| spellingShingle | Afana Hatem B. Ashokan Shine Nau Thomas Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study SICOT-J acl reconstruction thromboprophylaxis deep vein thrombosis venous thromboembolism |
| title | Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study |
| title_full | Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study |
| title_fullStr | Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study |
| title_full_unstemmed | Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study |
| title_short | Venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction: retrospective case-control study |
| title_sort | venous thromboembolism prophylaxis after anterior cruciate ligament reconstruction retrospective case control study |
| topic | acl reconstruction thromboprophylaxis deep vein thrombosis venous thromboembolism |
| url | https://www.sicot-j.org/articles/sicotj/full_html/2025/01/sicotj250049/sicotj250049.html |
| work_keys_str_mv | AT afanahatemb venousthromboembolismprophylaxisafteranteriorcruciateligamentreconstructionretrospectivecasecontrolstudy AT ashokanshine venousthromboembolismprophylaxisafteranteriorcruciateligamentreconstructionretrospectivecasecontrolstudy AT nauthomas venousthromboembolismprophylaxisafteranteriorcruciateligamentreconstructionretrospectivecasecontrolstudy |